Group 1: Company Overview and Financial Performance - In 2025, the company achieved an operating revenue of 108,644.87 million, a year-on-year increase of 0.92% [1] - The net profit attributable to shareholders was 21,476.85 million, a decrease of 22.60% compared to the previous year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 21,485.16 million, down 18.66% year-on-year [1] Group 2: Business Segment Performance - The software information segment saw a revenue growth of 6.22%, with power software products growing by 1.39% [2] - The electric smart instruments and operation services segment generated revenue of 225 million, a year-on-year increase of 14.42%, with a gross margin of 57.16% [2] - The environmental smart instruments and operation services segment experienced a revenue decline of 17.43%, primarily due to a 76.68% drop in environmental smart instrument integration business [2] Group 3: Cash Flow and Financial Management - The net cash flow from operating activities increased by 97.43%, significantly exceeding the net profit for the period [3] - Strong cash flow is attributed to the maturity of previously purchased time deposits, depreciation, and effective capital management [4] - The company has implemented refined financial controls, enhancing the efficiency of fund usage and turnover [4] Group 4: Future Outlook and Strategic Initiatives - The company is focusing on data procurement and optimizing product structures to address cyclical pressures in the environmental sector [3] - Investments in AI smart monitoring stations and unmanned operation equipment are being increased to drive innovation [3] - The company has secured national and provincial environmental monitoring operation projects, with an order backlog of 368 million [3]

Core Viewpoint - The Chinese banking industry is entering a deep transformation cycle after the "golden decade," facing pressures from macroeconomic adjustments, interest rate liberalization, stringent financial regulations, and technological disruptions [1][2][3] Group 1: Industry Challenges - The banking sector is experiencing intensified differentiation, with traditional scale expansion models becoming unsustainable [3] - Banks are facing four pressures: low interest rates, narrow interest margins, high risks, and strong regulations [2] - As of March 29, 2025, the average net interest margin of 13 disclosed banks is expected to narrow to around 1.5%, a year-on-year decline of 10 basis points, and a drop of nearly 60 basis points compared to 2020 [2] Group 2: Digital Transformation - Some banks are attempting to break through traditional business models by embracing digital transformation, with large and medium-sized banks establishing dedicated technology finance departments [4][5] - Despite the establishment of digital strategies, most banks remain at a basic stage of digitalization, focusing on replacing manual processes with digital tools [5] - Leading banks are expected to reduce operational costs by 15%-20% and improve return on equity by 4 percentage points through deep integration of AI technology into core business processes [5] Group 3: Strategic Shifts - The transition to digital and intelligent operations is no longer optional but a necessity for survival in the banking sector [6][14] - Banks like China Merchants Bank and Ping An Bank are integrating AI into their financial services, while Industrial and Commercial Bank of China is building a "Digital ICBC" ecosystem [6] - The focus on digital transformation is reflected in the financial performance of banks, with some achieving continuous revenue and profit growth [6][25] Group 4: Asset Management and Risk - The traditional asset operation model heavily relies on manual experience, making it difficult to achieve precise pricing and dynamic risk control [11] - The banking sector is facing an "asset shortage" due to a slowdown in financing demand from traditional industries and a mismatch between traditional credit evaluation systems and the characteristics of emerging industries [10][11] - Banks are increasingly recognizing the need to support technology-driven enterprises with innovative financial products that consider intangible assets [16][25] Group 5: Future Trends - The banking industry is expected to witness three major trends: the integration of digital intelligence into core business processes, the emergence of specialized sectors to avoid homogenized competition, and a shift towards serving the real economy [30][32] - The focus will shift from scale expansion to value creation, aligning with national strategies on modern industrial systems and technological innovation [33] - Banks that successfully integrate digital intelligence with core operations will gain competitive advantages, while those that remain at a basic level of digitalization may be phased out [31][36]

Group 1 - The core theme of the event is the advancement of all-tab technology and leadership in the large cylindrical battery market, with the second cylindrical battery technology forum scheduled for April 10, 2026, in Shenzhen [1] - The event is organized by Qidian Lithium Battery and Qidian Research Institute SPIR, with multiple sponsors and speakers from various companies in the lithium battery sector [1][4] - The forum will feature a ranking of the top 20 cylindrical battery manufacturers, highlighting industry leaders and innovations [1][4] Group 2 - Guoxuan High-Tech's testing laboratory has achieved a significant milestone by having three PACK laboratories certified by the Volkswagen Group, making it the company with the most certified testing facilities in China [2][5] - The certification signifies that Guoxuan High-Tech has established a comprehensive testing system covering the entire battery production chain, from cell to battery pack, meeting global standards [5][7] - The collaboration with Volkswagen has led to the development of a multi-matrix testing laboratory layout, enhancing Guoxuan's testing capabilities and supporting the development and mass production of battery systems [5][6] Group 3 - The certification process has been praised by Volkswagen's testing center officials, who noted the successful scale production and delivery of battery cells, as well as the extension of cooperation to battery pack levels [6][7] - Guoxuan High-Tech is focusing on digital transformation in its testing processes, implementing smart monitoring systems and automated report generation to enhance quality control and compliance verification [9] - The company aims to continue accelerating its intelligent transformation and strengthen its core technical capabilities to align with Volkswagen's global strategic needs [9]

Core Viewpoint - Shanghai Pharmaceuticals reported a revenue of 283.58 billion yuan for 2025, marking a year-on-year growth of 3.03%, and a net profit attributable to shareholders of 5.725 billion yuan, reflecting a 25.74% increase [1] Group 1: Financial Performance - The company achieved a net cash inflow from operating activities of 6.154 billion yuan, up 5.61% year-on-year [1] - The pharmaceutical industrial sector showed significant improvements in quality and efficiency, with a milestone in innovative research and development [1] Group 2: Innovation and R&D - The company’s first-class innovative drug, Apixaban, received market approval, and the new drug pipeline reached 59 projects, with 6 innovative drugs entering Phase III clinical trials [1] - Key projects such as Renqi Shurong Wan and SHPL-49 showed promising progress [1] Group 3: Production and Cost Management - The company deepened its digital transformation in production, achieving a 22% reduction in comprehensive energy consumption per unit product [2] - Cost management initiatives resulted in savings exceeding 40 million yuan [1][2] Group 4: Marketing and Sales - The company had 40 products with sales exceeding 100 million yuan, with 60 key varieties generating sales of 13.443 billion yuan [1] - The launch of the first improved new drug, Amisulpride orally disintegrating tablets, was successful, and the OTC and health business accelerated to become a second growth curve [1] Group 5: Commercial Sector and Strategic Initiatives - The pharmaceutical commercial sector maintained industry leadership, with core and innovative businesses growing simultaneously [2] - The CSO business surpassed 10 billion yuan in scale, and innovative drug service sales reached 53.7 billion yuan [2] Group 6: Digital Transformation - The company emphasized digital transformation as a key development strategy, integrating technology with core business operations [2] - Over 30 "AI+" projects were implemented, and two core data products were listed on the Shenzhen Data Exchange [2] Group 7: Future Outlook - For 2026, the company plans to adjust market strategies, accelerate international expansion, and optimize innovation resource allocation [3] - The company aims to become a leading enterprise in the pharmaceutical industry through robust operational strategies and a commitment to innovation [3]

Group 1: Company Strategy and Transformation - The company will accelerate its strategic transformation focusing on four key areas: green, global, digital, and ecological [3][4] - The green transformation will involve providing integrated solutions for new energy and accelerating the industrialization of alternative fuel internal combustion engines such as methanol and hydrogen [3][4] - The global transformation aims to deepen overseas market development and localization to ensure healthy growth and enhance global brand reputation [3][4] Group 2: Data Center Power Business - The company’s data center power products are progressing well, covering all scenarios in the power market and providing diverse energy solutions [4] - In 2025, the company sold nearly 11,000 M-series engines, with 1,401 units for data centers, representing a year-on-year growth of 259% [4] - In 2026, the company plans to significantly develop its power energy sector, focusing on product planning and capacity construction to meet growing customer demand [4] Group 3: Overseas Market Expansion - The company will enhance its global strategy by strengthening product preparation and channel development for data center products, expanding high-end customers in Europe and the U.S., and improving overseas service and aftermarket support [4][10] Group 4: Financial Performance and Outlook - Kion Group's revenue for 2025 is projected to decline slightly to €11.3 billion, with adjusted EBIT of €790 million, but new orders are increasing [2][6] - The efficiency improvement plan is expected to save approximately €150 million annually, with positive impacts anticipated in 2026 [2][6] - Revenue for 2026 is expected to grow by 1% to 9%, reaching between €11.4 billion and €12.3 billion, with adjusted EBIT projected to increase by 8% to 32% [6] Group 5: Research and Development Focus - Future R&D investments will focus on upgrading to National VI standards, developing high-end engineering machinery engines, and advancing new generation gas engines and alternative fuel technologies [7] - The company will also enhance its data center gas power products to larger displacement and higher power outputs [7]

Core Insights - The company reported a revenue of 25.201 billion yuan and a total profit of 2.067 billion yuan for the year 2025, marking a year-on-year growth of 17.37% in total profit and 10.76% in net profit attributable to shareholders after deducting non-recurring gains and losses [1] Group 1: Business Performance - The container manufacturing business generated a revenue of 22.131 billion yuan, with nearly 1.8 million TEUs sold in 2025 [2] - The shipping leasing business achieved a revenue of 2.063 billion yuan, managing a fleet of over 200 vessels and maintaining a leading position in the domestic shipping leasing industry [2] - The container leasing business reported a revenue of 5.531 billion yuan, with a container fleet exceeding 4.1 million TEUs by the end of 2025, enhancing the global service network [2] Group 2: Innovation and Technology - The company invested nearly 320 million yuan in technology research and development in 2025, focusing on deepening collaboration between industry, academia, and research [3] - The integration of AI and smart manufacturing into business operations is a key driver for quality improvement and expansion [3] Group 3: Future Outlook - The company aims to enhance its core competitiveness in production, finance, and investment, optimizing capacity layout in the container manufacturing business [4] - The shipping leasing business plans to expand the scale of quality assets and strengthen customer relationships [4] - The container leasing business will focus on innovation and customized service solutions to deepen customer value creation [4] - The company will continue to integrate ESG governance with strategic business initiatives to enhance intrinsic value [5]

Group 1: Company Strategic Transformation - The company will accelerate its transformation in four key areas: green, globalization, digital intelligence, and ecological strategies [2][3] - Green transformation focuses on providing integrated solutions for new energy and accelerating the industrialization of alternative fuels like methanol and hydrogen [2] - Globalization efforts include deepening overseas market development and enhancing local operations to ensure safe and healthy growth [2][3] Group 2: Data Center Power Business - The company plans to develop its data center power products, which currently cover all market demands, providing diverse energy solutions [3] - In 2025, the company expects to sell approximately 11,000 M-series engines, with 1,401 units for data centers, marking a 259% year-on-year increase [3] Group 3: Overseas Market Expansion Strategy - The company aims to strengthen its global strategy by preparing data center products and expanding channels, particularly targeting high-end clients in Europe and the U.S. [3] - Plans include accelerating localization projects and enhancing overseas service and market promotion efforts [3] Group 4: Future Performance Outlook - Kion Group's revenue is projected to decline slightly by 1.8% to €11.3 billion in 2025, with adjusted EBIT expected to drop by 14% [4] - However, new orders are showing growth, and cost-saving measures are expected to yield significant benefits in 2026 [4] Group 5: R&D Investment Focus - Future R&D investments will align with the green transformation, focusing on optimizing engine product lines and developing new technologies for alternative fuels [4] - The company will also enhance its data center products and continue investing in new energy technologies [4] Group 6: Heavy Truck Export Trends - During the 14th Five-Year Plan, China's heavy truck exports are expected to rise from 60,000 to 340,000 units, indicating a solid growth trajectory [4] - The company aims to transition from traditional exports to localized operations and services, enhancing its competitive edge in the global market [4] Group 7: Company Growth Points for 2026 - The heavy truck industry is expected to reach a scale of around 1.2 million units in 2026, with the company focusing on optimizing product and business structures [5] - The company anticipates significant growth from Kion Group's orders and the promotion of data center products [5] Group 8: Dividend Policy - In 2025, the company's cash dividend (including buybacks) is projected to account for 65% of the annual net profit attributable to shareholders [5] - The company plans to maintain a proactive and stable dividend policy, aiming to increase the cash dividend payout ratio when conditions allow [5]

Core Viewpoint - Shanghai Pharmaceuticals has reported a steady growth in revenue and significant advancements in its R&D pipeline, indicating a strong foundation for future growth and innovation in the pharmaceutical industry [1][11]. Financial Performance - The company achieved a revenue of 283.58 billion yuan, a year-on-year increase of 3.03% [1][11]. - The pharmaceutical manufacturing segment generated sales of 24.52 billion yuan, up 3.33%, while the pharmaceutical commercial segment reached 259.06 billion yuan, growing by 3.00% [1][11]. - R&D investment totaled 2.604 billion yuan, accounting for 10.62% of manufacturing sales, with R&D expenses at 2.340 billion yuan, representing 9.54% of manufacturing sales [1][11]. - Operating cash flow net inflow was 6.154 billion yuan, reflecting a 5.61% increase year-on-year [1][11]. R&D and Innovation - 2025 marked a pivotal year for innovation, with the approval of the first-class innovative drug, Apixaban, providing a new treatment option for over 300 million patients with primary hypertension [2][13]. - The company has 59 new drug applications in clinical research, including 47 innovative drugs and 12 modified new drugs, with one application accepted for market and six in Phase III clinical trials [2][13]. - Significant progress in key new drug projects includes the acceptance of applications for BCD-085 for ankylosing spondylitis and B001 for neuromyelitis optica spectrum disorder [3][14]. Upgrading R&D Ecosystem - The company is enhancing its self-developed technology platforms and has established collaborations with Shanghai Jiao Tong University for drug innovation [4][15]. - The company has made substantial advancements in traditional Chinese medicine, with several products included in authoritative guidelines and a total of 87 products passing consistency evaluations [4][15]. Industrial Transformation - The pharmaceutical manufacturing sector is undergoing a digital transformation, with significant improvements in smart manufacturing and cost reduction measures [5][16]. - The company has implemented over 100 cost-reduction measures and achieved a 22% reduction in energy consumption per product [5][16]. - The industrial sales included 40 products exceeding 100 million yuan, with four products surpassing 1 billion yuan in sales [5][16]. Commercial Sector Growth - The commercial segment has seen robust growth, with the CSO business exceeding 10 billion yuan and innovative drug services generating 53.7 billion yuan in revenue [6][17]. - The company has expanded its national sales network to cover 25 provinces, with eight provinces achieving sales over 10 billion yuan [6][17]. Digital Transformation and AI Integration - The company is accelerating its digital transformation, implementing AI applications across various sectors, including R&D and production [8][18]. - A comprehensive digital management system has been established, covering over 50 ongoing projects in R&D [8][18]. International Expansion - The company is actively pursuing international business opportunities, with significant growth in Southeast Asia and the Middle East [9][20]. - The company has submitted multiple registration applications for traditional Chinese medicine in Hong Kong and achieved notable sales growth in its overseas subsidiaries [9][20]. Strategic Vision for Future Growth - As part of the "14th Five-Year Plan," the company aims to enhance its core competencies and focus on high-quality development, emphasizing innovation and transformation [10][21]. - The company plans to strengthen its supply chain services and expand its market presence in both domestic and international markets [10][21].

Core Viewpoint - In 2025, Evergrande Property faces dual challenges of industry-wide pressures and specific historical issues, initiating a transformation centered on "breaking the deadlock" and "restructuring," focusing on quality and efficiency to improve operational fundamentals, cash flow, and asset structure, demonstrating strong operational resilience [1][12]. Financial Quality - Revenue for Evergrande Property reached 13.678 billion yuan in 2025, a year-on-year increase of 7.2%, maintaining a steady growth trend [2][13]. - Gross profit was 2.505 billion yuan, up 2.5%, with a gross margin of 18.3%, down 0.9 percentage points; net profit was 1.009 billion yuan, down 2.2%, with a net margin of 7.4%, down 0.7 percentage points, primarily due to increased investments in service quality and digital platform development [2][13]. - Cash and cash equivalents reached 4.190 billion yuan, a significant increase of 55.32% year-on-year, driven by increased net cash inflow from operating activities [3][14]. Business Structure and Revenue Composition - Property management service revenue was 11.498 billion yuan, up 7.6%, accounting for 84.1% of total revenue, with core property management service revenue at 11.470 billion yuan, up 8.3%, driven by an expanded managed area and improved collection rates [3][14]. - Community life service revenue was 1.009 billion yuan, up 10.7%, becoming a key growth driver, with significant contributions from convenience services, community retail, home services, and cultural tourism services [4][15]. - Asset management service revenue was 798 million yuan, up 2.7%, with a high gross margin of 48.7%, contributing significantly to profitability [5][16]. Market Expansion - By the end of 2025, Evergrande Property managed an area of 601 million square meters, providing a stable customer base and revenue source [7][18]. - Third-party revenue reached 13.645 billion yuan, up 7.7%, accounting for 99.8% of total revenue, indicating a steady increase in market independence and core capabilities [7][18]. - Non-residential projects accounted for 80% of new signed projects, with significant growth in sectors like rail transit and healthcare, enhancing the company's competitive edge [8][19]. Service Quality - Evergrande Property emphasizes a customer-centric service philosophy, focusing on improving service quality through various initiatives, including facility upgrades and standardized communication [9][20]. - The company has integrated AI and data-driven approaches to enhance operational efficiency and customer experience, covering over 90% of managed areas and reaching nearly 400,000 customers [10][21]. Overall Outlook - Evergrande Property is gradually reducing reliance on related parties, accelerating market development, and improving financial health and core competitiveness, positioning itself for resilient growth amid industry transformation [11][23].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致的任何損失承擔任何責任。 HISENSE HOME APPLIANCES GROUP CO., LTD. 海信家電集團股份有限公司 （在中華人民共和國註冊成立的股份有限公司） （股份代號：00921） 海外市場監管公告 本公告乃根據香港聯合交易所有限公司證券上市規則第 13.10B 條而作出。 《海信家電集團股份有限公司 2025 年年度報告》、《海信家電集團股份有限公司 2025 年年度報告摘要》、《海信家電集團股份有限公司 2025 年年度審計報告》已刊載於深圳 證券交易所指定之信息披露網站：http://www.cninfo.com.cn，以供參閱。 承董事會命 海信家電集團股份有限公司 董事長 高玉玲 中國廣東省佛山市，2026 年 3 月 30 日 於本公告日期，本公司的執行董事為高玉玲女士、賈少謙先生、于芝濤先生、方雪玉女 士及代慧忠先生；本公司的獨立非執行董事為李志剛先生、蔡榮星先生及徐國君先生； 及本公司的職工代 ...